Meyer-Losic, F., Quinonero, J., Dubois, V., Alluis, B., Dechambre, M., Michel, M., Cailler, F., Fernandez, A.M., Trouet, A. and Kearsey, J. (2006) Improved Therapeutic Efficacy of Doxorubicin through Conjugation with a Novel Peptide Drug Delivery Technology (Vectocell). Journal of Medicinal Chemistry, 49, 6908-6916.
https://doi.org/10.1021/jm0606591

has been cited by the following article:

• TITLE: Triphenylmethanol Conjugates of Triptorelin as Anti-Lipid Peroxidation Prodrugs

  AUTHORS: Samiyah Alhamed, Jawzah Alnakhli, William Boadi, Ryan Beni

  KEYWORDS: Antioxidants, Prodrugs, Triptorelin, Polyphenols, Lipid Peroxidation, Triphenylmethanol

  JOURNAL NAME: Open Journal of Medicinal Chemistry, Vol.9 No.3, July 26, 2019

  ABSTRACT: Antioxidants are substances that can prevent or slow damage to cells caused by free radicals, unstable molecules that the body produces as a reaction to environmental and other pressures. Free radicals may play a role in heart disease, cancer and other diseases. If the body cannot process and remove free radicals efficiently, oxidative stress can result. This can harm cells and body function. Free radicals are also known as reactive oxygen species (ROS). In this research, Triptorelin® (TRP) conjugates of triphenylmethanol derivatives (TPMs) were synthesized to evaluate their in vitro lipid peroxidation potency. Comparative lipid peroxidation assays between TRP-TPMs conjugates and the corresponding TPMs derivatives were measured using thiobarbituric reactive substance (TBARS) in a dose- and time-dependent manner following the Fenton’s pathway. Overall, TBARS decreased between 20% - 30% for the treated samples of synthesized conjugates compared to their respective control physical mixtures. These data suggest that TRP-TPMs derivatives can be used to improve the biological activity of TRP.